Research Collaborations
To stay at the forefront, AcouSort is continuously developing the acoustofluidic technology further together with universities and commercial partners.
BioWings
Develoment of actuation materials together with universities and commercial partners to make acoustofluidic chips more efficient and easier to manufacture.
The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 801267.
AcouPlast
Development of polymer acoustophoresis chips together with universites and commercial partners to make acoustofluidics even more versatile, cost efficient and easy to integrate into diagnostic and analytical systems.
The project has received funding from the Eurostarts-2 joint programme with co-funding from the European Union Horizon 2020 research and innovation programme. The Swedish part is funded by Sweden’s Innovation Agency Vinnova.
Centre for Advanced Medical Products (CAMP)
Development of cell development together with universities and commercial partners.
The project is funded by Sweden’s Innovation Agency Vinnova.
Previous projects
Leucocyte isolation based on acoustophoresis (LIBA, 2014-2015)
Development of acoustofluidic separation of mononuclear cells (MNCs) from blood in collaboration with Lund University and Skåne University Hospital. The project was funded by Sweden’s Innovation Agency Vinnova.
Read MoreA unique tool for the isolation of cells including cancer diagnostics and microbiology (2014-2015)
Development of an acoustofluidic instrument for cell and particle handling. The project was funded by the Sten K Johnson Foundation.
Read MoreAcouPlasma (2018-2019)
The AcouPlasma SME instrument project developed the business plan and strategy for AcouSort’s market positioning of a cost-effective Lab-on-a-chip solution for blood plasma separation, intended for integration into plasma-based diagnostic devices. The project was funded by the European Union’s Horizon 2020 research and innovation programme.
Read More